• Log in with Facebook Log in with Twitter Log In with Google      Sign In    
  • Create Account
  LongeCity
              Advocacy & Research for Unlimited Lifespans

Photo

SB 242784 -- A Possible Therapeutic Approach to Vascular Calcification


  • Please log in to reply
3 replies to this topic

#1 Aphrodite

  • Guest, F@H
  • 106 posts
  • 9

Posted 05 November 2009 - 03:40 PM


There is not much that can be done currently in regards to prevention and treatment of arterial calcification. Some people have suggested supplementing with vitamin K, although solid studies appear to be lacking. I was browsing through a book entitled "Biological Calcification: Normal and Pathological Processes in the Early Stages" and came across an interesting study conducted on rats. It appears that an osteoclast inhibitor named SB 242784 has the potential to inhibit aterial calcification (specifically in vitamin-D intoxicated rats).


"Studies by Dhore et al. (2001) showed the constitutive immunoreactivity of MGP, OC and BSP, and the absence of OPN, BMP-2, BMP-4 and ON, in normal human aortas; the calcification or ossification of atherosclerotic plaques were associated with up-regulation of the latter (OPN, BMP-2, BMP-4 and ON,) and sustained immunoreactivity of the former (MGP,OC and BSP). Moreover, the same authors found that osteoprotegerin (OPG), an osteoclastogenesis inhibitory factor, and its ligand (RANKL), were detectable in normal aortas and early atherosclerotic lesions, and that, in advanced calcified plaques, OPG was present in bone structures and RANKL was only detectable around calcified deposits. In this connection, it has been 14.3 Ectopic Calcifications 401 reported by Bucay et al. (1998) that OPG−/− mice exhibited osteoporosis, as expected, but unexpectedly developed widespread calcification of the aortas and renal arteries, suggesting that OPG inhibits artery calcification, as demonstrated later (Price et al. 2001). These findings, which suggest a link between the local factors that regulate osteoclasticbone resorption, the immune system and calcification of the arterial wall (Schoppet et al. 2002; Collin-Osdoby 2004), have found support in the observation that the inhibition of osteoclast activity by SB 242784 – a selective inhibitor of the osteoclast V-H+-ATPase – prevents arterial calcification in vitamin D-intoxicated rats (Price et al. 2002)."


Edited by Aphrodite, 05 November 2009 - 03:41 PM.


#2 kismet

  • Guest
  • 2,984 posts
  • 424
  • Location:Austria, Vienna

Posted 05 November 2009 - 04:29 PM

You're reading the wrong studies. Vitamin K is in a whole different league compared to this osteoclast inhibitor. ;)

sponsored ad

  • Advert
Click HERE to rent this MEDICINES advertising spot to support LongeCity (this will replace the google ad above).

#3 AgeVivo

  • Guest, Engineer
  • 2,114 posts
  • 1,555

Posted 05 November 2009 - 10:06 PM

Hi Kismet,

you seem to know this subject well

Vitamin K is in a whole different league compared to this osteoclast inhibitor.

? do you mean that vitamin K is much better at preventing vascular calcification?
doesn't vitamin K also thickens the blood? do you know if mice live longer under vitamin K?

sponsored ad

  • Advert
Click HERE to rent this MEDICINES advertising spot to support LongeCity (this will replace the google ad above).

#4 kismet

  • Guest
  • 2,984 posts
  • 424
  • Location:Austria, Vienna

Posted 05 November 2009 - 10:14 PM

? do you mean that vitamin K is much better at preventing vascular calcification?
doesn't vitamin K also thickens the blood? do you know if mice live longer under vitamin K?

It normalises clotting if you are deficient (up to a point and no higher), which possibly raises risk of thrombotic events (i.e. deficiency may be protective, but it's probably a trade-off of thrombotic vs hemorrhagic events).
Yes, VK is superior because it has been used in more models, has been shown by many observational trials to protect homo sapiens from calcification (or possibly CHD & other), has a known safety track record, etc (as compared to this highly experimental treatment which may be unique to the VDN model).
VK is unlikely to extend life span, though, deficiency could shorten life span.  ;)




1 user(s) are reading this topic

0 members, 1 guests, 0 anonymous users